ZALMOXI-CV Duo 457

Zalmoxi-CV Duo 457 is a pediatric dry syrup oral suspension containing amoxycillin (400 mg) and clavulanic acid (57 mg) per 5 ml. This higher-strength “DUO” formulation provides a convenient dosing option for children, reducing the frequency of administration. It is indicated for the treatment of bacterial infections including respiratory tract infections, urinary tract infections, ENT infections, skin and soft tissue infections, and gastrointestinal infections.

ZALCLAV-CV LB

Zalclav-CV LB is a pediatric dry syrup formulation that contains amoxycillin , clavulanic acid and lactic acid bacillus . This combination is used in children for the treatment of bacterial infections such as respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections. The lactic acid bacillus helps maintain gut flora and reduces the risk of antibiotic-associated diarrhea, improving tolerance and compliance in pediatric patients.

ZALMOXI - DDS

Zalmoxi-DDS is a dry syrup oral suspension that contains amoxycillin, a broad-spectrum penicillin antibiotic, and clavulanic acid, a beta-lactamase inhibitor. This dual drug system (DDS) formulation enhances antibacterial activity by protecting amoxycillin from enzymatic degradation. It is prescribed in pediatric patients for respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections caused by susceptible bacteria. The DDS pack ensures stability and accurate dosing after reconstitution.